Navigation Links
Politics has taken notice of science

This release is available in German.

The objective, serious and highly responsible debate was very impressive, said the President of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Professor Matthias Kleiner, summing up his feelings following the first reading of the amendment of the Stem Cell Act in the Federal Parliament. He emphasised that he was very pleased about how clearly the voice of the scientific community had been heeded by the politicians. He also highlighted the fact that the compromise between the freedom to conduct research and ethical restrictions that was reached in 2002 had been thrown off kilter, as there were now only a very few stem cells available for research purposes in Germany, and that they are largely contaminated. This balance thus needs to be restored, either by doing away with the existing qualifying date entirely, or by postponing it.

The Vice President of the DFG, Professor Jrg-Hinrich Hacker, from Wrzburg, who is responsible for biomedical issues, highlighted the fact that the debate on importing stem cells had been conducted on the basis of the existing Embryo Protection Act, which the scientific community had always been in favour of retaining. The recent success in reprogramming adult cells would have been impossible without the research conducted using embryonic stem cells. Further progress in this field would, he said, be inconceivable without comparative studies. Without thorough basic research, Hacker continued, it would also be impossible to develop any therapeutic method in the field of regenerative medicine. Patience is an essential part of the nature of basic research. No form of therapy is yet to be expected in this central, forward-looking field of research.

In a statement on the future of stem cell research in Germany released in November 2006, the DFG recommended that the current so-called qualifying date rule should be abolished and the threat of punishment hanging over German scientists should be lifted. It thus welcomes the fact that all of the parties involved in the current debate in the Federal Parliament evidently see the question of punishing German scientists collaborating with foreign colleagues in this area as being outdated and obsolete. The DFG recognises this as a sign that the distrust of German stem cell researchers has ceased to exist.

The DFG wishes to point out again, quite clearly, that imported stem cell lines may still only be harvested from so-called supernumerary embryos, in other words embryos that are no longer required for reproductive purposes.


Contact: Eva-Maria Streier
Deutsche Forschungsgemeinschaft

Related medicine news :

1. The Fight for His Life: Author, Family Battle Disease and Challenge Politics in the Face of Survival
2. Blunt: Time to Stop the Politics on SCHIP, and Start the Negotiations
3. TV Documentary Examines Three Decades of Tobacco Politics, Policies and People in Minnesota
4. S&P: Leverage Tops Politics as Primary Credit Concern for U.S. Health Care Companies, Says S&P
5. The politics of the playground: lack of athletic skill often means loneliness and peer rejection
6. DNC: Bush Republicans Care More About Politics Than Our Nations Kids
7. New book sheds light on conflicts of politics and science
8. Clues to ensuring anti-HIV drugs are taken in Africa
9. New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves
10. Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdaq
11. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)...  As the latest Obamacare repeal effort moves is ... (R-LA) and Lindsey Graham (R-SC) medical device ... industry is in an odd place.  The industry wants ... tax on medical device sales passed along with the ... increased visits and hospital customers with the funding to ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: